INVERNESS MEDICAL TECHNOLOGY INC/DE
S-4, EX-5.1, 2000-12-04
LABORATORY ANALYTICAL INSTRUMENTS
Previous: INVERNESS MEDICAL TECHNOLOGY INC/DE, S-4, 2000-12-04
Next: INVERNESS MEDICAL TECHNOLOGY INC/DE, S-4, EX-8.1, 2000-12-04



<PAGE>

                    [Goodwin, Procter & Hoar LLP Letterhead]

                                                                     Exhibit 5.1



                                               November __, 2000



Inverness Medical Technology, Inc.
200 Prospect Street
Waltham, MA 02453



         We are rendering this opinion in connection with the Registration
Statement on Form S-4 (the "Registration Statement") filed by Inverness Medical
Technology, Inc. (the "Company") with the Securities and Exchange Commission
under the Securities Act of 1933, as amended (the "Securities Act"), on or about
the date hereof. The Registration Statement relates to up to 1,900,000 shares
(the "Merger Shares") of the Company's common stock, $0.001 par value per share,
to be issued in connection with the merger of Integ Incorporated ("Integ") with
and into a wholly owned subsidiary of the Company, pursuant to the Agreement and
Plan of Merger dated as of October 3, 2000, as amended by the First Amendment to
Agreement and Plan of Merger, dated as of October 16, 2000 (the "Agreement")
among the Company, such subsidiary and Integ. We understand that the Merger
Shares are to be offered and sold in the manner described in the Registration
Statement.

         In connection with rendering this opinion, we have examined the
following documents (collectively, the "Documents"): (i) the Registration
Statement and the exhibits thereto; (ii) the Agreement; (iii) the Certificate of
Incorporation and By-laws of the Company, each as amended and amended and
restated to date; (iv) such records of the corporate proceedings of the Company
as we deemed material; and (v) such other certificates, receipts, records and
documents as we have considered necessary for the purpose of this opinion. In
our examination, we have assumed the genuineness of all signatures, the legal
capacity of natural persons, the authenticity of all documents submitted to us
as certified, photostatic or facsimile copies, the authenticity of he originals
of such copies and the authenticity of telephonic confirmation of public
officials and others. As to facts material to our opinion, we have relied upon
certificates or telephonic confirmations of public officials and certificates,
documents, statements and other information of the Company or representatives or
officers thereof.

         We are attorneys admitted to practice in the Commonwealth of
Massachusetts. We express no opinion concerning the laws of any jurisdiction
other than the laws of the United States of America, the laws of the
Commonwealth of Massachusetts and the General Corporation Law of the State of
Delaware (which includes applicable provisions of the Delaware Constitution and
reported judicial decisions interpreting the Delaware General Corporation Law
and the Delaware Constitution).
<PAGE>

         Based upon the foregoing, we are of the opinion that when issued and
delivered and paid for as contemplated in the Documents, the Merger Shares will
be duly authorized, validly issued, fully paid and nonassessable by the Company.

         The foregoing assumes that all requisite steps will be taken to comply
with the requirements of the Securities Act and applicable requirements of state
laws regulating the offer and sale of securities.

         We hereby consent to the inclusion of this opinion as an exhibit to the
Registration Statement and to the reference to our firm under the heading "Legal
Matters" in the proxy statement and prospectus which is part of the Registration
Statement.

                                     Very truly yours,

                                     /s/ Goodwin, Procter, & Hoar  LLP


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission